REQUEST A DEMO
Total
USD $0.00
Search more companies

Orzaks Ilac Ve Kimya Sanayi Ticaret A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Orzaks Ilac Ve Kimya Sanayi Ticaret Anonim Sirketi Profile Updated: January 19, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Orzaks Ilac Ve Kimya Sanayi Ticaret A.S. is an enterprise in Turkiye, with the main office in Istanbul. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on October 22, 2004. It currently has a total number of 263 (2025) employees. From the latest financial highlights, Orzaks Ilac Ve Kimya Sanayi Ticaret A.S. reported a net sales revenue increase of 35.84% in 2023. Its’ total assets recorded a negative growth of 15.11%. The net profit margin of Orzaks Ilac Ve Kimya Sanayi Ticaret A.S. increased by 2.63% in 2023.

Headquarters
No:27a Akcaburgaz Mahallesi 153. Sokak Esenyurt
Istanbul; Marmara; Postal Code: 34522

Contact Details: Purchase the Orzaks Ilac Ve Kimya Sanayi Ticaret A.S. report to view the information.

Website: http://www.orzax.com

Basic Information
Total Employees:
Purchase the Orzaks Ilac Ve Kimya Sanayi Ticaret A.S. report to view the information.
Financial Auditors:
Purchase the Orzaks Ilac Ve Kimya Sanayi Ticaret A.S. report to view the information.
Incorporation Date:
October 22, 2004
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Orzaks Ilac Ve Kimya Sanayi Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
35.84%
Total operating revenue
35.84%
Operating Profit/Loss (EBIT)
57.18%
Net Profit/Loss for the Period
75.89%
Total Assets
-15.11%
Total Equity
2.81%
Operating Profit Margin (ROS)
4.09%
Net Profit Margin
2.63%
Return on Equity (ROE)
17.99%
Debt/Equity
-26.96%
Quick Ratio
0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?